Cite
Soto-Ortolaza AI, Heckman MG, Labbé C, et al. GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis. 2013;2(4):287-99
Soto-Ortolaza, A. I., Heckman, M. G., Labbé, C., Serie, D. J., Puschmann, A., Rayaprolu, S., Strongosky, A., Boczarska-Jedynak, M., Opala, G., Krygowska-Wajs, A., Barcikowska, M., Czyzewski, K., Lynch, T., Uitti, R. J., Wszolek, Z. K., & Ross, O. A. (2013). GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. American journal of neurodegenerative disease, 2(4), 287-99.
Soto-Ortolaza, Alexandra I, et al. "GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16." American journal of neurodegenerative disease vol. 2,4 (2013): 287-99.
Soto-Ortolaza AI, Heckman MG, Labbé C, Serie DJ, Puschmann A, Rayaprolu S, Strongosky A, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Lynch T, Uitti RJ, Wszolek ZK, Ross OA. GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis. 2013 Nov 29;2(4):287-99. eCollection 2013. PMID: 24319646; PMCID: PMC3852568.
Copy
Download .nbib